Xuli Meng
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Immunology
- Pulmonary and Respiratory Medicine
- Topics
- Cancer Cells and Metastasis (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)Breast Cancer Treatment Studies (5 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xuli Meng
41 papers receiving 785 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Molecular Biology 489
- Oncology 257
- Cancer Research 220
- Immunology 128
- Pulmonary and Respiratory Medicine 114
Countries citing papers authored by Xuli Meng
This map shows the geographic impact of Xuli Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuli Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuli Meng more than expected).
Fields of papers citing papers by Xuli Meng
This network shows the impact of papers produced by Xuli Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuli Meng. The network helps show where Xuli Meng may publish in the future.
Co-authorship network of co-authors of Xuli Meng
This figure shows the co-authorship network connecting the top 25 collaborators of Xuli Meng. A scholar is included among the top collaborators of Xuli Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuli Meng. Xuli Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 10 | |
| 8 | 20 | |
| 9 | 7 | |
| 10 | 38 | |
| 11 | 9 | |
| 12 | 28 | |
| 13 | 5 | |
| 14 | 54 | |
| 15 | 34 | |
| 16 | 102 | |
| 17 | 14 | |
| 18 | 48 | |
| 19 | 5 | |
| 20 | 12 |
About Xuli Meng
Xuli Meng is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 43 papers that have together received 792 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Cancer Research (220 citations), Oncology (257 citations) and Molecular Biology (489 citations). Xuli Meng has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Qinghui Zheng, Long Zhang, Fangfang Zhou, Heyu Li, Hongchao Tang, Bin Wang, Mengdi Zhang, Jie Qiu, Peng Su and Feng Xie. Their work appears in journals such as Nature, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.